Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
The American Journal of Pathology
|
December 7, 2000
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti, D Waltregny, J Dilks, et al.
The Journal of Urology
|
February 25, 1998
Low p27 expression predicts poor disease-free survival in patients with prostate cancer
R M Yang, J Naitoh, M Murphy, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 1, 2001
Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27
D Waltregny, I Leav, S Signoretti, et al.
Cancer Research
|
April 1, 1997
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
P Tan, B Cady, M Wanner, et al.
Pathology, Research and Practice
|
June 1, 1992
Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry
A K Lee, B Wiley, J M Dugan, et al.
Japanese Journal of Cancer Research : Gann
|
August 18, 2001
Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers
H Sasaki, K M Lo, L B Chen, et al.
The New England Journal of Medicine
|
December 5, 1996
The DCC protein and prognosis in colorectal cancer
D Shibata, M A Reale, P Lavin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 1, 1992
DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma
A K Lee, B Wiley, M Loda, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 1, 1997
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis
C Magi-Galluzzi, R Mishra, M Fiorentino, et al.
Cancer Research
|
August 15, 1997
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
V Esposito, A Baldi, A De Luca, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
The American Journal of Pathology
|
December 7, 2000
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti, D Waltregny, J Dilks, et al.
The Journal of Urology
|
February 25, 1998
Low p27 expression predicts poor disease-free survival in patients with prostate cancer
R M Yang, J Naitoh, M Murphy, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 1, 2001
Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27
D Waltregny, I Leav, S Signoretti, et al.
Cancer Research
|
April 1, 1997
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
P Tan, B Cady, M Wanner, et al.
Pathology, Research and Practice
|
June 1, 1992
Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry
A K Lee, B Wiley, J M Dugan, et al.
Japanese Journal of Cancer Research : Gann
|
August 18, 2001
Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers
H Sasaki, K M Lo, L B Chen, et al.
The New England Journal of Medicine
|
December 5, 1996
The DCC protein and prognosis in colorectal cancer
D Shibata, M A Reale, P Lavin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 1, 1992
DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma
A K Lee, B Wiley, M Loda, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 1, 1997
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis
C Magi-Galluzzi, R Mishra, M Fiorentino, et al.
Cancer Research
|
August 15, 1997
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
V Esposito, A Baldi, A De Luca, et al.
Page
of 11